$DOX

Why is Amdocs stock cratering 40% today?

Amdocs stock fell 39.4% to $37.83 after issuing a weak fiscal 2027 outlook due to a legal dispute with T-Mobile, its largest customer. Q4 2026 results met expectations, but FY2027 revenue is projected to decline 14.3%-17.9% and adjusted EPS to fall 26%-30%. Oppenheimer downgraded the stock, and analysts revised earnings forecasts downward. The company also announced a $340M acquisition, adding to financial pressures.

Original reporting
Published Nov 4, 2026, 9:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 9:51 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$DOX
Bearish
high confidence
Mentioned
$DOX
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DOXBearishHigh
01

Why it matters

The guidance cut and downgrade suggest near‑term earnings pressure, prompting a steep pre‑market sell‑off.

02

Market read

Amdocs' stock fell ~40% on news of a severe guidance downgrade and a high‑profile customer dispute, creating immediate trading opportunity.

03

What to watch

The $340 M acquisition of EIS may provide long‑term upside once integration progresses.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Amdocs reported FY2026 Q4 results in line with expectations but issued a markedly weaker FY2027 outlook amid a legal battle with its largest U.S. customer, T‑Mobile.

Company-level read

Ticker impact

$DOXBearishHigh confidence
Context

Amdocs disclosed FY2027 revenue down 14.3%-17.9% and EPS down 26%-30% plus a T‑Mobile legal dispute, triggering a 39.4% pre‑market plunge.

Expected impact

likely further downside pressure as the market prices in weaker outlook and dispute risk.

Evidence & confidence

The guidance revision is material, the stock already fell 39% pre‑open, and no mitigating news was provided.

Market effects

Amdocs' decline highlights exposure risk for telecom‑software vendors reliant on a few large carriers.

U.S. equities may see modest drag despite broader index gains.

Limited to U.S. tech and telecom sectors.

Counterpoint

If the T‑Mobile dispute resolves favorably, the stock could rebound sharply from oversold levels.

Key entities

  • Amdocs

    U.S. software provider for telecom operators.

  • T‑Mobile

    Amdocs' largest North American customer.

Related articles

$DOXHighAI 9/10

Amdocs (DOX) Q4 2026 Earnings Call Transcript

Amdocs (DOX) announced an 8-year deal with AT&T and other strategic agreements with VEON, Globe, and VodafoneThree to adopt its AOS technology. The company also acquired EIS, an insurance software provider, for $340M. Amdocs plans to expand into the insurance market and has optimized its portfolio to focus on its agentic strategy. The company reported progress in internal transformation and provided FY2027 revenue growth guidance.

$DOXMedAI 8/10

Amdocs share price tanks as T-Mobile US dispute weighs heavily

Amdocs' share price dropped 42% after reporting a 3.6% revenue rise to $4.7bn, due to a contract dispute with T-Mobile US. The dispute may lead to arbitration or legal action, and Amdocs expects a 7-11% revenue decline in the coming year. Despite this, Amdocs secured new contracts with Vodafone, AT&T, and others, and acquired EIS for $340m to expand into insurance technology.

$DOXHighAI 9/10

Amdocs drama: Stock crashes 45%

Amdocs' stock fell 45% after hours due to a weak 2027 forecast tied to a legal dispute with T-Mobile. The company reported a 9.6% drop in its 12-month order backlog to $3.5B and annual revenue of $4.7B, up 3.5%. Amdocs also announced a new contract with AT&T and acquired EIS for $340M to expand into insurance.

$DOXHighAI 9/10

Why is Amdocs stock plummeting today?

Amdocs (DOX) stock fell 44.5% after-hours due to a fiscal 2027 outlook that missed expectations, citing a legal dispute with T-Mobile. Q4 2026 results met expectations, but Q1 2027 revenue guidance was 19% below consensus, and full-year EPS is projected to decline 26-30%. Oppenheimer downgraded the stock, and multiple analysts cut earnings estimates. The company is also exiting non-strategic businesses, adding to revenue uncertainty.